FDA inspection
Takeda Austria GmbH: FDA inspection ending Sep 11, 2025
FDA inspection 1291316 · No Action Indicated (NAI) · Linz
Key facts
| Inspection ID | 1291316 |
|---|---|
| Firm | Takeda Austria GmbH |
| FEI number | 3001157285 |
| Address | Sankt-Peter-Strase 25 |
| City | Linz |
| Country | Austria |
| Fiscal year | 2025 |
| Inspection end date | Sep 11, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data